Summit Therapeutics SMMT
NASDAQ SMMT
$16.40 +0.92 (+5.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Other Accumulated Expenses (2019 - 2026)

Updated

Summit Therapeutics (SMMT) reported Other Accumulated Expenses of $2.62 million for Q2 2026, up 76.6% from $1.49 million a year earlier and up 128.4% from the prior quarter.

Analysis

Summit Therapeutics (SMMT) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, Summit Therapeutics posted Other Accumulated Expenses of $2.28 million, up 27.0% from FY2024.

  • Other Accumulated Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 25.6% (FY2020 to FY2025).
  • By year, Other Accumulated Expenses came in at $1.8 million in FY2024 (+150.6%), $717,000 in FY2023 (+8.3%), $662,000 in FY2022 (-26.2%) and $897,000 in FY2021 (+23.0%).
  • The Q2 2026 figure ranks as the highest quarterly Other Accumulated Expenses in data going back to Q4 2019.
  • Year over year, Other Accumulated Expenses has now increased in each of the last five quarters, with growth averaging 73.6% over the last eight quarters.
  • The high point for year-over-year Other Accumulated Expenses in five years was Q3 2021 (growth of 191.0%); the low point was Q3 2022 (a decline of 79.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.15 million (Q1 2026), $2.28 million (Q4 2025) and $1.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Summit Therapeutics 12.28 Bn 10.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.62 Mn
Mar 31, 2026 1.15 Mn
Dec 31, 2025 2.28 Mn
Sep 30, 2025 1.96 Mn
Jun 30, 2025 1.49 Mn
Mar 31, 2025 759,000.00
Dec 31, 2024 1.80 Mn
Sep 30, 2024 1.03 Mn
Jun 30, 2024 806,000.00
Mar 31, 2024 788,000.00
Dec 31, 2023 717,000.00
Sep 30, 2023 484,000.00
Jun 30, 2023 619,000.00
Mar 31, 2023 320,000.00
Dec 31, 2022 662,000.00
Sep 30, 2022 209,000.00
Jun 30, 2022 265,000.00
Mar 31, 2022 678,000.00
Dec 31, 2021 897,000.00
Sep 30, 2021 1.03 Mn
API Access

Summit Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SMMT&period=max&api_key=YOUR_API_KEY